Finally, the frequency of cells expressing high level of MIPβ (CCL4) and IRF8 (cluster 7) was significantly lower in the mixed cluster of HLA-DR+ T cells and B cells from patients with early MS than in healthy controls (Fig. 6d–f). Here, CCL4 is linked to myeloid sarcoma.